These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 15800319

  • 1. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
    Vandesompele J, Baudis M, De Preter K, Van Roy N, Ambros P, Bown N, Brinkschmidt C, Christiansen H, Combaret V, Lastowska M, Nicholson J, O'Meara A, Plantaz D, Stallings R, Brichard B, Van den Broecke C, De Bie S, De Paepe A, Laureys G, Speleman F.
    J Clin Oncol; 2005 Apr 01; 23(10):2280-99. PubMed ID: 15800319
    [Abstract] [Full Text] [Related]

  • 2. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Lampert F, Boecker W, Dockhorn-Dworniczak B.
    Med Pediatr Oncol; 2001 Jan 01; 36(1):11-3. PubMed ID: 11464859
    [Abstract] [Full Text] [Related]

  • 3. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
    Spitz R, Hero B, Simon T, Berthold F.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3368-73. PubMed ID: 16740759
    [Abstract] [Full Text] [Related]

  • 4. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N.
    N Engl J Med; 1999 Jun 24; 340(25):1954-61. PubMed ID: 10379019
    [Abstract] [Full Text] [Related]

  • 5. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P.
    Cancer; 2002 Feb 01; 94(3):854-61. PubMed ID: 11857322
    [Abstract] [Full Text] [Related]

  • 6. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
    Spitz R, Hero B, Ernestus K, Berthold F.
    Clin Cancer Res; 2003 Jan 01; 9(1):52-8. PubMed ID: 12538451
    [Abstract] [Full Text] [Related]

  • 7. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
    Spitz R, Hero B, Ernestus K, Berthold F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4835-40. PubMed ID: 14581355
    [Abstract] [Full Text] [Related]

  • 8. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R.
    N Engl J Med; 1996 Jan 25; 334(4):225-30. PubMed ID: 8531999
    [Abstract] [Full Text] [Related]

  • 9. Overall genomic pattern is a predictor of outcome in neuroblastoma.
    Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D, Vermeulen J, Couturier J, Peuchmaur M, Valent A, Plantaz D, Rubie H, Valteau-Couanet D, Thomas C, Combaret V, Rousseau R, Eggert A, Michon J, Speleman F, Delattre O.
    J Clin Oncol; 2009 Mar 01; 27(7):1026-33. PubMed ID: 19171713
    [Abstract] [Full Text] [Related]

  • 10. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
    Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B.
    Cancer Genet Cytogenet; 2006 May 01; 167(1):51-6. PubMed ID: 16682287
    [Abstract] [Full Text] [Related]

  • 11. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P, Oberthuer A, Fischer M, Westermann F, Eils R, Brors B.
    BMC Cancer; 2007 May 25; 7():89. PubMed ID: 17531100
    [Abstract] [Full Text] [Related]

  • 12. Comparative genomic hybridization (CGH) analysis of neuroblastomas--an important methodological approach in paediatric tumour pathology.
    Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F, Stoerkel S.
    J Pathol; 1997 Apr 25; 181(4):394-400. PubMed ID: 9196436
    [Abstract] [Full Text] [Related]

  • 13. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP, Diskin SJ, Wasserman N, Rinaldi K, Attiyeh EF, Cole K, Jagannathan J, Bhambhani K, Winter C, Maris JM.
    Genes Chromosomes Cancer; 2007 Oct 25; 46(10):936-49. PubMed ID: 17647283
    [Abstract] [Full Text] [Related]

  • 14. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
    George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT.
    J Clin Oncol; 2005 Sep 20; 23(27):6466-73. PubMed ID: 16116152
    [Abstract] [Full Text] [Related]

  • 15. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
    van Noesel MM, Hählen K, Hakvoort-Cammel FG, Egeler RM.
    Cancer; 1997 Sep 01; 80(5):834-43. PubMed ID: 9307181
    [Abstract] [Full Text] [Related]

  • 16. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.
    Cunsolo CL, Bicocchi MP, Petti AR, Tonini GP.
    Br J Cancer; 2000 Nov 01; 83(10):1295-300. PubMed ID: 11044353
    [Abstract] [Full Text] [Related]

  • 17. Molecular staging of intracranial ependymoma in children and adults.
    Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schöttler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S.
    J Clin Oncol; 2010 Jul 01; 28(19):3182-90. PubMed ID: 20516456
    [Abstract] [Full Text] [Related]

  • 18. ArrayCGH-based classification of neuroblastoma into genomic subgroups.
    Michels E, Vandesompele J, De Preter K, Hoebeeck J, Vermeulen J, Schramm A, Molenaar JJ, Menten B, Marques B, Stallings RL, Combaret V, Devalck C, De Paepe A, Versteeg R, Eggert A, Laureys G, Van Roy N, Speleman F.
    Genes Chromosomes Cancer; 2007 Dec 01; 46(12):1098-108. PubMed ID: 17823929
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
    Fischer M, Oberthuer A, Brors B, Kahlert Y, Skowron M, Voth H, Warnat P, Ernestus K, Hero B, Berthold F.
    Clin Cancer Res; 2006 Sep 01; 12(17):5118-28. PubMed ID: 16951229
    [Abstract] [Full Text] [Related]

  • 20. [The neuroblastoma, "enfant terrible" among pediatric tumors].
    Laureys G.
    Verh K Acad Geneeskd Belg; 2003 Sep 01; 65(1):5-23; discussion 23-8. PubMed ID: 12802894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.